Hap Trading, LLC Pfizer Inc Call Options Transaction History

Hap Trading, LLC

$873 Billion
Q1 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $157,929 - $181,353	6,100 Added 6.83%	95,400 $126 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $791,739 - $1.03 Million	30,300 Added 51.36%	89,300 $49.5 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $208,585 - $243,815	-6,500 Reduced 9.92%	59,000 $1.96 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $307,020 - $355,215	8,500 Added 14.91%	65,500 $2.4 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $2.39 Million - $3.11 Million	-60,600 Reduced 51.53%	57,000 $36,000

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $2.54 Million - $3.32 Million	-60,900 Reduced 34.12%	117,600 $282,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.23 Million - $1.5 Million	28,000 Added 18.6%	178,500 $130,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $5.73 Million - $6.79 Million	-123,100 Reduced 44.99%	150,500 $898,000
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $8.9 Million - $11 Million	-194,500 Reduced 41.55%	273,600 $1.07 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.1 Million - $1.63 Million	26,600 Added 6.02%	468,100 $4 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $4.79 Million - $6.16 Million	-122,100 Reduced 21.66%	441,500 $836,000
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $13.3 Million - $15.1 Million	371,000 Added 192.63%	563,600 $565,000
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $9.9 Million - $11.2 Million	-295,700 Reduced 60.56%	192,600 $222,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $6.28 Million - $7.99 Million	187,700 Added 62.44%	488,300 $482,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $1.85 Million - $2.17 Million	58,300 Added 24.06%	300,600 $400,000
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $4.67 Million - $5.67 Million	155,100 Added 177.87%	242,300 $132,000
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $443,292 - $633,368	16,400 Added 23.16%	87,200 $45,000
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $1.18 Million - $1.34 Million	-35,800 Reduced 33.58%	70,800 $79,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $1.75 Million - $2.27 Million	53,900 Added 102.28%	106,600 $52,000
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $1.21 Million - $1.36 Million	32,800 Added 164.82%	52,700 $86,000
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $2.49 Million - $2.73 Million	-66,300 Reduced 76.91%	19,900 $13,000
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $830,952 - $947,376	21,600 Added 33.44%	86,200 $287,000
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $10,341 - $12,543	300 Added 0.47%	64,600 $350,000
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $15.6 Million - $16.6 Million	-473,500 Reduced 88.04%	64,300 $52,000
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $16.1 Million - $18.6 Million	503,100 Added 1449.86%	537,800 $33,000
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $46,564 - $49,406	-1,400 Reduced 3.88%	34,700 $34,000
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $1.12 Million - $1.23 Million	36,100	36,100 $66,000

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

Vanguard Group Inc Valley Forge, PA

507M
Shares

$14.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

431M
Shares

$12.1 Billion
0.28% of portfolio
State Street Corp Boston, MA

291M
Shares

$8.13 Billion
0.37% of portfolio
Wellington Management Group LLP Boston, MA

178M
Shares

$4.97 Billion
0.89% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

122M
Shares

$3.42 Billion
0.79% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account